# GH and Cardiovascular Risk Factors

> **NCT01877512** · PHASE4 · COMPLETED · sponsor: **Amsterdam UMC, location VUmc** · enrollment: 32 (actual)

## Conditions studied

- Growth Hormone Deficiency
- Cardiovascular Diseases
- Metabolic Syndrome
- Cognition
- Physical Activity

## Interventions

- **DRUG:** Change in daily dosage of Growth Hormone

## Key facts

- **NCT ID:** NCT01877512
- **Lead sponsor:** Amsterdam UMC, location VUmc
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2014-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01877512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01877512, "GH and Cardiovascular Risk Factors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01877512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*